No dose adjustments are required for renal or hepatic impairment per FDA labeling, as tirzepatide is primarily metabolized through proteolytic pathways
Slowed digestion, reduced food intake, lower fiber consumption, dehydration, and electrolyte imbalance all play a role and in most cases, all of them need to be addressed together
Check your specific coverage at optumrx.com or call the number on your UHC ID card
Last reviewed: June 29, 2026 Last updated: June 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations